TGFB1 and COVID-19: Furthermore, TGF-β itself has been suggested to be involved in the promotion of COVID-19-associated pulmonary disease52 and, accordingly, both MDSC and TGF-β should be further investigated as pathogenic/prognostic factors and potential therapeutic targets in COVID-19.